Assignee
PEPGEN CORP
US·7 granted patents·6 pending applications·40 citations·filing 2001–2007
Top patents by PatentIndex Score
13 records- 0180US7695710B2Antitumor and antiviral combination therapies using low-toxicity, long-circulating human interferon-alpha analogsPEPGEN CORP·Filed 2007·Granted Apr 13, 2010·2 cites·6 claims
- 0280US7083782B2Method of treatment using interferon-tauPEPGEN CORP·Filed 2004·Granted Aug 1, 2006·15 cites·6 claims
- 0375US7431920B2Method of treating IL-10 deficiencyPEPGEN CORP·Filed 2005·Granted Oct 7, 2008·4 cites·9 claims
- 0473US7105154B2Method of treatment using interferon-tauPEPGEN CORP·Filed 2003·Granted Sep 12, 2006·10 cites·6 claims
- 0571US6982081B2Composition for treatment of and method of monitoring hepatitis C virus using interferon-TAUPEPGEN CORP·Filed 2001·Granted Jan 3, 2006·8 cites·9 claims
- 0666US7232563B2Hybrid interferon/interferon tau proteins, compositions and methods of usePEPGEN CORP·Filed 2002·Granted Jun 19, 2007·1 cites·8 claims
- 0755US2009035273A1Combination treatment method with interferon-tauPEPGEN CORP·Filed 2007·Application pending·0 cites
- 0849US7662370B2Low-toxicity, long-circulating human interferon-alpha PEGylated mutantsPEPGEN CORP·Filed 2006·Granted Feb 16, 2010·0 cites·3 claims
- 0949US2006078942A1Method of treatment using interferon-tauPEPGEN CORP·Filed 2005·Application pending·0 cites
- 1049US2006257363A1Treatment using an interferonPEPGEN CORP·Filed 2006·Application pending·0 cites
- 1148US2007081991A1Compositions and methods for modulation of immune responsesPEPGEN CORP·Filed 2006·Application pending·0 cites
- 1244US2005244373A1Composition for treatment of and method of monitoring hepatitis C virus using interferon-tauPEPGEN CORP·Filed 2005·Application pending·0 cites
- 1339US2006134750A1Method of treatment using interferon-tauPEPGEN CORP·Filed 2005·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →